Expansion of CD8(+) T cells lacking the IL-6 receptor α chain in patients with coronary artery diseases (CAD)

Atherosclerosis. 2016 Jun:249:44-51. doi: 10.1016/j.atherosclerosis.2016.03.038. Epub 2016 Apr 1.

Abstract

Background and aims: The pathogenesis of coronary artery disease (CAD) is closely associated with chronic inflammatory processes. CD8(+) T cells are a key participant in the pathogenesis of atherosclerosis, the major cause of CAD; however, it remains unclear which CD8(+) T-cell subset is responsible. We investigated the immunological features of CD8(+) T cells expressing low and high levels of the IL-6 receptor α chain (IL-6Rα), a cytokine known to play a key role in cardiovascular diseases.

Methods: The expression of IL-6Rα on CD8(+) T cells and its association with plasma levels of soluble components of the IL-6/IL-6Rs as well as with clinical parameters were analyzed using FACS analysis and ELISA of CAD patients and age-matched healthy controls (HCs). Immunological characteristics of CD8(+) T cells expressing low and high levels of IL-6Rα (CD8(+)IL-6Rα(low or high)) were examined by in vitro culture and intracellular FACS analysis.

Results: CAD patients had higher frequencies of circulating CD8(+)IL-6Rα(low) effector memory (EM) T cells compared with HCs (median frequency; 74.59% vs. 60.09%, p = 0.0158). Expanded CD8(+)IL-6Rα(low) T cells positively correlated with the frequency of senescent, cytotoxic CD8(+)CD57(+) T cells (r = 0.6655, p < 0.0001) and plasma IL-6 level (r = 0.3995, p = 0.0432) in CAD patients. Loss of IL-6Rα expression on CD8(+) T cells was induced by the combination of IL-6 and IL-15 with accompanying TCR-independent proliferation (p = 0.0101). Moreover, these CD8(+)IL-6Rα(low) T cells had features of type 1 cytotoxic CD8(+) T cells.

Conclusions: Our findings suggest the possible involvement of expanded CD8(+)IL-6Rα(low) EM T cells in CAD through their pro-inflammatory and highly cytotoxic capacities.

Keywords: CD8(+) T cells; Coronary artery disease; IL-6 receptor α chain; Interleukin-6; Type 1 cytotoxic T cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • CD8-Positive T-Lymphocytes / cytology*
  • CD8-Positive T-Lymphocytes / metabolism*
  • Cell Separation
  • Coronary Artery Disease / genetics*
  • Female
  • Flow Cytometry
  • Humans
  • Inflammation
  • Interleukin-15 / metabolism
  • Interleukin-6 / blood
  • Male
  • Middle Aged
  • Receptors, Interleukin-6 / genetics*
  • Receptors, Interleukin-6 / metabolism*
  • T-Lymphocyte Subsets / cytology
  • T-Lymphocyte Subsets / metabolism

Substances

  • IL15 protein, human
  • IL6 protein, human
  • IL6R protein, human
  • Interleukin-15
  • Interleukin-6
  • Receptors, Interleukin-6